Dhuley J N, Naik S R
Pharmacology and Toxicology Division, Research Centre, Hindistan Antibiotics Limited, Pimpri, Pune, India.
J Ethnopharmacol. 1998 Dec;63(3):219-25. doi: 10.1016/s0378-8741(98)00085-3.
The effect of Rhinax on gastric damage in different animal models including gastric ulceration induced by a necrotic agent such as 0.6 N HCl, indomethacin, and intragastric distension was studied. Treatment with Rhinax at a dose of 160 mg/kg protected gastric mucosa against the damage induced by oral administration of indomethacin and intragastric distension. The volume and acidity of gastric juice in pyloric ligated rats was reduced by Rhinax. It also significantly promoted gastric mucus secretion in normal animals. On the basis of these observations, we conclude that Rhinax possesses anti-ulcer activity and that the observed activity may be due to the modulation of defensive factors by improvement in gastric cytoprotection.
研究了瑞纳克斯(Rhinax)对不同动物模型胃损伤的影响,这些模型包括由坏死剂如0.6N盐酸、吲哚美辛诱导的胃溃疡以及胃内扩张。以160mg/kg的剂量给予瑞纳克斯可保护胃黏膜免受口服吲哚美辛和胃内扩张所诱导的损伤。瑞纳克斯可降低幽门结扎大鼠胃液的体积和酸度。它还能显著促进正常动物的胃黏液分泌。基于这些观察结果,我们得出结论,瑞纳克斯具有抗溃疡活性,且观察到的活性可能是由于通过改善胃细胞保护作用来调节防御因子所致。